WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Raccontata datheguardian.comtelegraph.co.uknytimes.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
nytimes.comStai leggendo10 mesi fa

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

originale
telegraph.co.uk11 mesi fa

The amazing rise and shocking fall of the company that created Ozempic

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

Leggi questa versione → originale
theguardian.com11 mesi fa

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 6 agosto 2025·theguardian.com

    Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

    Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

  2. mercoledì 6 agosto 2025·telegraph.co.uk

    The amazing rise and shocking fall of the company that created Ozempic

    A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

  3. giovedì 7 agosto 2025·nytimes.com

    How Ozempic Maker Novo Nordisk Lost Its Shine

    The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.